Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development.

Autor: Karunakaran KP; Vaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, B.C., Canada; Department of Biology, Faculty of Science and Technology, Douglas College, New Westminster, B.C., Canada., Yu H; Vaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, B.C., Canada., Jiang X; Vaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, B.C., Canada., Chan QWT; Department of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, B.C., Canada., Sigola L; Department of Biology, Faculty of Science and Technology, Douglas College, New Westminster, B.C., Canada., Millis LA; Department of Biology, Faculty of Science and Technology, Douglas College, New Westminster, B.C., Canada., Chen J; Department of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, B.C., Canada., Tang P; Weill-Cornell Medical College, Doha, Qatar., Foster LJ; Department of Biochemistry and Molecular Biology, Michael Smith Laboratories, University of British Columbia, Vancouver, B.C., Canada., Brunham RC; Vaccine Research Laboratory, University of British Columbia Centre for Disease Control, Vancouver, B.C., Canada. Electronic address: robert.brunham@bccdc.ca.

Publikováno v: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126266. Date of Electronic Publication: 2024 Sep 03.